We are live on ! Find out more
PARS

PHARMOS CORP NEW
PARS

Delisted

PARS was delisted on the 12th of March, 2009.

Back to rankings

1 hedge funds and large institutions have $12 invested in PHARMOS CORP NEW in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more capital invested

Capital invested by funds: $3 → $12 (+$9)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AWA
1
Arkadios Wealth Advisors
Georgia
$12 – – –

PARS Hedge Fund Activity: Q2 2020 in Review

1 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in PHARMOS CORP NEW (PARS) for Q2 2020, worth a combined $12 — up 300% from $3 a quarter earlier.

Fund positioning in PARS was balanced in Q2 2020: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held PHARMOS CORP NEW (PARS) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $12 of PHARMOS CORP NEW stock for Q2 2020, up 300% quarter-over-quarter.
  • 0 funds opened new PHARMOS CORP NEW positions in Q2 2020 and 0 closed out.

Based on aggregated 13F filings for Q2 2020.